Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

S8 File - by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

Study populations of included studies. by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

Future research directions. by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

PRISMA flow diagram. by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

S9 File - by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

S7 File - by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

Participant characteristics of included studies. by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

The sequences of si-RNAs used in this study. by Changji Li (4806930)

Subjects:

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”

Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

“…Each mesh exhibited selective responses to the target VOCs, with no significant impact on the dynamic range observed in either the single or tandem configurations (EtOH 1–300 ppm, AcH 0.2–5 ppm). …”